serious effects such as pancreatitis, hypoglycaemia, and injection site reactions should be reported to your clinical team promptly
The Federal Bureau of Investigation also recently warned the public about safety concerns related to fraudulent compounding practices associated with weight loss drugs, warning that "[s]ome healthcare providers are using compounded mixtures of unknown drugs that do not contain semaglutide, drugs with high levels of impurities, and unsafe or unapproved drugs." Novo Nordisk is continuing to actively address this issue through education, advocacy, and legal action, fighting on behalf of patients who deserve to know what they are injecting into their body
This new treatment is setting a new standard for weight loss effectiveness
Unlike PPC ads, advertisers pay how often an ad is shown to someone
Wegovy pills require daily administration rather than weekly dosing, but the underlying mechanism once absorbed remains unchanged